[The Catecholamines in the Central Nervous System]

Overview

Journal Klin Wochenschr

Specialty General Medicine

Date 1960 Jan 15

PMID 14441534

Citations 10

Authors

I Sano

K Taniguchi

T Gamo

M Takesada

Y Kakimoto

Affiliations

Soon will be listed here.

Citing Articles

L-DOPA-therapy in Parkinson's disease: some personal reflections on L-DOPA therapy from Vienna and Berlin.

Riederer P, Horowski R J Neural Transm (Vienna). 2023; 130(11):1323-1335.

PMID: 37796288 PMC: 10645634. DOI: 10.1007/s00702-023-02692-9.

Dopamine in psychiatry: a historical perspective.

Foley P J Neural Transm (Vienna). 2019; 126(4):473-479.

PMID: 30758785 DOI: 10.1007/s00702-019-01987-0.

Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.

Uchihara T, Giasson B Acta Neuropathol. 2015; 131(1):49-73.

PMID: 26446103 PMC: 4698305. DOI: 10.1007/s00401-015-1485-1.

Dihydralazine inhibits tyrosine hydroxylase in vivo in the rat.

Persson B, Svensson T, Henning M J Neural Transm. 1982; 53(2-3):109-16.

PMID: 6122715 DOI: 10.1007/BF01243402.

Relation between the action of dopamine and apomorphine and their O-methylated derivatives upon the CNS.

ERNST A Psychopharmacologia. 1965; 7(6):391-9.

PMID: 5831877 DOI: 10.1007/BF00402361.

References

Pletscher A . [Effects of isonicotinic acid hydrazide on 5-hydroxytryptamine metabolism in brain]. Experientia. 1956; 12(12):479-80. DOI: 10.1007/BF02162532. View

VON EULER U, ORWEN I . Preparation of extracts of urine and organs for estimation of free and conjugated noradrenaline and adrenaline. Acta Physiol Scand Suppl. 1955; 33(118):1-9. View

HOLTZ P . [Sympathomimetic activity of brain extracts]. Acta Physiol Scand. 1950; 20(4):354-62. DOI: 10.1111/j.1748-1716.1950.tb00712.x. View

Shore P, Pletscher A, TOMICH E, Carlsson A, Kuntzman R, Brodie B . Role of brain serotonin in reserpine action. Ann N Y Acad Sci. 1957; 66(3):609-15; discussion, 615-7. DOI: 10.1111/j.1749-6632.1957.tb40751.x. View

Vogt M . The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. J Physiol. 1954; 123(3):451-81. PMC: 1366219. DOI: 10.1113/jphysiol.1954.sp005064. View

Holzbauer M, Vogt M . Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat. J Neurochem. 1956; 1(1):8-11. DOI: 10.1111/j.1471-4159.1956.tb12048.x. View

Pletscher A . [Effect of isopropyl-isonicotinic acid hydrazide on the metabolism of catechol amines and 5-hydroxytryptamine in the brain]. Schweiz Med Wochenschr. 1957; 87(50):1532-4. View

Sano I, Kakimoto Y, Taniguchi K . Binding and transport of serotonin in rabbit blood platelets and action of reserpine. Am J Physiol. 1958; 195(2):495-8. DOI: 10.1152/ajplegacy.1958.195.2.495. View

Brodie B, Shore P . A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann N Y Acad Sci. 1957; 66(3):631-42. DOI: 10.1111/j.1749-6632.1957.tb40753.x. View

10.

Carlsson A, Lindqvist M, Magnusson T, WALDECK B . On the presence of 3-hydroxytyramine in brain. Science. 1958; 127(3296):471. DOI: 10.1126/science.127.3296.471. View

11.

Horita A . beta-Phenylisopropylhydrazine, a potent and long acting monoamine oxidase inhibitor. J Pharmacol Exp Ther. 1958; 122(2):176-81. View

12.

ZELLER E, BARSKY J . In vivo inhibition of liver and brain monoamine oxidase by 1-Isonicotinyl-2-isopropyl hydrazine. Proc Soc Exp Biol Med. 1952; 81(2):459-61. DOI: 10.3181/00379727-81-19910. View

13.

WEIL-MALHERBE H, Bone A . The chemical estimation of adrenaline-like substances in blood. Biochem J. 1952; 51(3):311-8. PMC: 1197847. DOI: 10.1042/bj0510311. View